Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients

Launched by ASSIUT UNIVERSITY · Jul 25, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how anxiety, depression, sleep quality, and overall quality of life are affected in patients with Systemic Lupus Erythematosus (SLE), which is a chronic autoimmune disease. The study aims to understand how these mental health factors relate to the activity of the disease itself. To do this, researchers will compare SLE patients to healthy individuals to see how their experiences differ.

To participate in this study, you need to be diagnosed with SLE based on specific criteria. However, if you have severe heart, liver, or kidney problems, or a history of significant psychological disorders, you won't be eligible to join. If you qualify, you can expect to share information about your mental health, sleep, and daily life during the study. This research will help improve understanding of how SLE impacts not just physical health, but emotional well-being too.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients diagnosed with SLE according to the 2012 systemic lupus international collaborating clinics (SLICC) criteria .
• Exclusion Criteria:
• • Evidence of end-organ failures such as heart failure, liver cell or renal failure,
• • History of psychological disorders .